Prostaglandins and cancer: a review of tumor initiation through tumor metastasis.

[1]  H. Broxmeyer,et al.  REGULATION OF HUMAN MYELOPOIESIS BY PROSTAGLANDIN E AND LACTOFERRIN , 1981, Cell and tissue kinetics.

[2]  K. Honn,et al.  Prostacyclin: a potent antimetastatic agent. , 1981, Science.

[3]  T. Eling,et al.  Prostaglandin synthetase-dependent cooxidation of (+/-)-benzo(a)pyrene-7,8-dihydrodiol by human lung and other mammalian tissues. , 1981, Cancer research.

[4]  K. Honn,et al.  Prostaglandin Analogs as Inhibitors of Tumor Cell DNA Synthesis 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[5]  B. Goldstein,et al.  Retinoid inhibition of superoxide anion radical production by human polymorphonuclear leukocytes stimulated with tumor promoters. , 1980, Biochemical and biophysical research communications.

[6]  B. Jaffe,et al.  The interactions between indomethacin and cytotoxic drugs in mice bearing B-16 melanomas. , 1980, Prostaglandins.

[7]  T. Slaga,et al.  Indomethacin enhancement of TPA tumor promotion in mice. , 1980, Cancer letters.

[8]  L. Marnett,et al.  Hydroperoxide-dependent oxygenation of trans-7,8-dihydroxy-7,8-dihydro benzo[a]pyrene by ram seminal vesicle microsomes. Source of the oxygen. , 1980, Biochemical and biophysical research communications.

[9]  R. Bockman.  Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins. , 1980, The Journal of clinical investigation.

[10]  M. Droller,et al.  Production of prostaglandin E2 by tumor cells in vitro. , 1980, Cancer research.

[11]  Y. Honma,et al.  Regulation of prostaglandin synthesis during differentiation of cultured mouse myeloid leukemia cells , 1980, Journal of cellular physiology.

[12]  F. Schaefer,et al.  Induction of abnormal development and differentiation in cultured mammary glands by cyclic adenine nucleotide and prostaglandins , 1980, Nature.

[13]  T. Zenser,et al.  Mechanism of FANFT cooxidation by prostaglandin endoperoxide synthetase. , 1980, The Journal of pharmacology and experimental therapeutics.

[14]  H. Armbrecht,et al.  Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase. , 1980, Cancer research.

[15]  W. Piacibello,et al.  Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E1. , 1980, Cancer research.

[16]  H. Broxmeyer,et al.  Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1. , 1980, Cancer research.

[17]  H. Koeffler,et al.  Humoral modulation of human acute myelogenous leukemia cell growth in vitro. , 1980, Cancer research.

[18]  J. Jacquemier,et al.  Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. , 1980, Journal of the National Cancer Institute.

[19]  N. Williams,et al.  Limitation of macrophage production in long‐term marrow cultures containing prostaglandin E , 1980, Journal of cellular physiology.

[20]  T. Narisawa,et al.  Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. , 1980, Gan.

[21]  E. Garaci,et al.  The effect of PGA1 on the immune response in B-16 melanoma-bearing mice. , 1980, Prostaglandins.

[22]  V. Turk,et al.  Neutral proteinase inhibitors and antimetastatic effects in mice. , 1980, European journal of cancer.

[23]  S. Collins,et al.  Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL‐60) by compounds which induce differentiation of murine leukemia cells , 1980, International journal of cancer.

[24]  M. A. Tuttle,et al.  Comparison of the mutagenicities of malondialdehyde and the side products formed during its chemical synthesis. , 1980, Cancer research.

[25]  A. Verma,et al.  Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. , 1980, Cancer research.

[26]  M. Beaven,et al.  Evidence that prostaglandins do not have a role in the cytostatic action of anti-inflammatory drugs. , 1980, Biochemical pharmacology.

[27]  R. Carter,et al.  Prostaglandin-like material extracted from squamous carcinomas of the head and neck. , 1980, British Journal of Cancer.

[28]  D. Barkla,et al.  Influence of prostaglandin analogues on epithelial cell proliferation and xenograft growth. , 1980, British Journal of Cancer.

[29]  H. Svaar,et al.  Content and distribution of macrophages and lymphocytes in solid malignant human tumours , 1979, International journal of cancer.

[30]  T. Zenser,et al.  Cooxygenation by prostaglandin cyclooxygenase from rabbit inner medulla. , 1979, Kidney international.

[31]  T. Zenser,et al.  Cooxidation of benzidine by renal medullary prostaglandin cyclooxygenase. , 1979, The Journal of pharmacology and experimental therapeutics.

[32]  F. Fitzpatrick,et al.  Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells , 1979, Nature.

[33]  R. Bockman,et al.  Increased prostaglandin synthesis by macrophages from tumor-bearing mice. , 1979, Journal of immunology.

[34]  M. Goldyne,et al.  Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations. , 1979, The Journal of clinical investigation.

[35]  H. Mukhtar,et al.  Arachidonic acid‐dependent metabolism of (±) trans‐7,8‐dihydroxy‐7,8‐ dihydro‐benzo[a]pyrene (BP‐7,8 diol) to 7,10/8,9 tetrols , 1979, FEBS letters.

[36]  D. Leaper,et al.  Breast cancer and prostaglandins: A new approach to treatment , 1979, The British journal of surgery.

[37]  L. Marnett,et al.  Arachidonic acid‐dependent metabolism of 7,8‐dihydroxy‐7,8‐dihydrobenzo[a]pyrene by ram seminal vesicles , 1979, FEBS letters.

[38]  C. Ashendel,et al.  Prostaglandin E and F levels in mouse epidermis are increased by tumor-promoting phorbol esters. , 1979, Biochemical and biophysical research communications.

[39]  R. Bockman,et al.  Prostaglandin E inhibition of T-lymphocyte colony formation: a possible mechanism of monocyte modulation of clonal expansion. , 1979, The Journal of clinical investigation.

[40]  H. Broxmeyer,et al.  Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin , 1979, The Journal of experimental medicine.

[41]  L. Marnett,et al.  Peroxidatic oxidation of benzo[a]pyrene and prostaglandin biosynthesis. , 1979, Biochemistry.

[42]  E. Bresnick,et al.  Epidermal prostaglandins after topical application of a tumor promotor. , 1979, Cancer letters.

[43]  F. Marks,et al.  The effect of indomethacin on cell proliferation induced by chemical and mechanical means in mouse epidermis in vivo. , 1979, Research communications in chemical pathology and pharmacology.

[44]  Y. Honma,et al.  Inhibition of differentiation of cultured mouse myeloid leukemia cells by nonsteroidal antiinflammatory agents and counteraction of the inhibition by prostaglandin E1. , 1979, Cancer research.

[45]  B. Jaffe,et al.  Prostaglandin A1 induces differentiation in Friend erythroleukemia cells. , 1979, Prostaglandins.

[46]  L. Marnett,et al.  Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents. , 1979, Biochemical and biophysical research communications.

[47]  B. Jaffe,et al.  Inhibition of Friend erythroleukaemia-cell tumours in vivo by a synthetic analogue of prostaglandin E2. , 1979, British Journal of Cancer.

[48]  W. Jubiz,et al.  Inhibitory Effect of Prostaglandin F2α on the Growth of a Hormone-dependent Rat Mammary Tumor , 1979 .

[49]  R. Clark.  Systemic cancer and the metastatic process , 1979, Cancer.

[50]  B. Jaffe,et al.  Effect of endogenous and exogenous prostaglandin E on Friend erythroleukaemia cell growth and differentiation. , 1979, British Journal of Cancer.

[51]  P. Baudhuin,et al.  Inhibition of the discharge of endocytosed protein from phagosomes into lysosomes in hepatoma cells exposed to dimerized ribonuclease A. , 1979, The Biochemical journal.

[52]  K P Dingemans,et al.  Mechanisms of metastasis. , 1979, Biochimica et biophysica acta.

[53]  W. Kibbey,et al.  Prostaglandin synthetase and prostaglandin E2 levels in human breast carcinoma. , 1979, Prostaglandins and medicine.

[54]  D. Leaper,et al.  Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen. , 1979, Prostaglandins.

[55]  T. Eling,et al.  Metabolism of benzo(a)pyrene to reactive intermediate(s) via prostaglandin biosynthesis. , 1978, Life sciences.

[56]  T. Zenser,et al.  Differential distribution of the mixed-function oxidase activities in rabbit kidney. , 1978, The Journal of pharmacology and experimental therapeutics.

[57]  A. Miller,et al.  Modulation of granulopoiesis: opposing roles of prostaglandins F and E. , 1978, The Journal of laboratory and clinical medicine.

[58]  M. Hampton,et al.  Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase , 1978, Nature.

[59]  F. Kuehl,et al.  Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases by mouse peritoneal macrophages. , 1978, The Biochemical journal.

[60]  F. Marks,et al.  Indomethacin inhibition of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in mouse epidermis in vivo. , 1978, Biochemical and biophysical research communications.

[61]  J. Salomon,et al.  Mechanism of inhibition of tumour growth by aspirin and indomethacin. , 1978, British Journal of Cancer.

[62]  J. Vane,et al.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. , 1978, Pharmacological reviews.

[63]  H. Broxmeyer,et al.  Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. , 1978, Blood.

[64]  L. Marnett,et al.  Prostaglandin synthetase dependent activation of 7,8-dihydro-7,8-dihydroxy-geno (a) pyrene to mutagenic derivativies. , 1978, Biochemical and biophysical research communications.

[65]  T. Powles,et al.  Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesis. , 1978, Biochemical pharmacology.

[66]  A. Lupulescu.  Enhancement of carcinogenesis by prostaglandins , 1978, Nature.

[67]  H. Broxmeyer,et al.  Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E. , 1978, Science.

[68]  D. Jerina,et al.  Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice. , 1978, Cancer research.

[69]  W. Kibbey,et al.  PROSTAGLANDINS AND METASTASIS , 1978, The Lancet.

[70]  A. Verma,et al.  Prostaglandins and skin tumor promotion: inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis. , 1977, Biochemical and biophysical research communications.

[71]  A. Hassid,et al.  Effects of phorbol-12,13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cells. , 1977, Biochemical and biophysical research communications.

[72]  L. Marnett,et al.  Prostaglandin synthetase dependent benzo(a)pyrene oxidation: products of the oxication and inhibition of their formation by antioxidants. , 1977, Biochemical and biophysical research communications.

[73]  R. Williams,et al.  Prostaglandin-producing suppressor cells in Hodgkin's disease. , 1977, The New England journal of medicine.

[74]  E. Granström,et al.  Albumin stabilizes thromboxane A2 , 1977, FEBS letters.

[75]  B. Jaffe,et al.  Dose dependent inhibition of B-16 melanoma growth in vivo by a synthetic analogue of PGE2. , 1977, Prostaglandins.

[76]  K. Gollahon,et al.  Detection and quantitation of macrophage infiltration into primary human tumors with the use of cell-surface markers. , 1977, Journal of the National Cancer Institute.

[77]  B. Jaffe,et al.  Inhibition of B-16 melanoma growth in vivo by a synthetic analog of prostaglandin E2. , 1977, Cancer research.

[78]  T. Żebro,et al.  PROSTAGLANDINS AND BREAST CANCER , 1977, The Lancet.

[79]  P. Majerus,et al.  Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. , 1977, Biochemical and biophysical research communications.

[80]  M. Moore,et al.  Modulation of hemopoiesis by prostaglandins. , 1977, Experimental hematology.

[81]  C. Harris,et al.  Structures of benzo(a)pyrene–nucleic acid adducts formed in human and bovine bronchial explants , 1977, Nature.

[82]  A. Tashjian,et al.  Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin. , 1977, Prostaglandins.

[83]  J. Lazo,et al.  Neurite extension and malignancy of neuroblastoma cells after treatment with prostaglandin E1 and papaverine. , 1977, Journal of the National Cancer Institute.

[84]  T. Żebro,et al.  Prostaglandins from tumours of human large bowel. , 1977, British Journal of Cancer.

[85]  Sugarbaker Ev,et al.  Mechanisms and prevention of cancer dissemination: an overview. , 1977 .

[86]  L. Weiss.  A pathobiologic overview of metastasis. , 1977, Seminars in oncology.

[87]  L. Levine,et al.  Elevated prostaglandins synthetase activity in methylcholanthrene-transformed mouse BALB/3T3. , 1977, Prostaglandins.

[88]  B. Jaffe,et al.  Inhibition of tumour growth in vivo and in vitro by prostaglandin E , 1976, Nature.

[89]  V. Hial,et al.  Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. , 1976, European journal of pharmacology.

[90]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[91]  B. Goldstein,et al.  Mutagenicity of malonaldehyde, a decomposition product of peroxidized polyunsaturated fatty acids. , 1976, Science.

[92]  L. Sachs,et al.  Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[93]  E Wetzler,et al.  Letter: Type-iv hyperlipidaemia. , 1975, Lancet.

[94]  L. Marnett,et al.  Co-oxygenation of organic substrates by the prostaglandin synthetase of sheep vesicular gland. , 1975, The Journal of biological chemistry.

[95]  R. Boutwell,et al.  Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. , 1975, Cancer research.

[96]  R. Franklin,et al.  Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit. , 1975, Metabolism: clinical and experimental.

[97]  P. Rudland,et al.  Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F2alpha. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[98]  A. Bennett,et al.  BREAST CANCER, PROSTAGLANDINS, AND BONE METASTASES , 1975, The Lancet.

[99]  J. Humes,et al.  Prostaglandin synthesis inhibition: Effect on bone changes and sarcoma tumor induction in balb/c mice , 1975, International journal of cancer.

[100]  Allan H. Smith,et al.  Subversion of immune system by tumor cells and role of prostaglandins. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[101]  R. Shamberger,et al.  Antioxidants and cancer. IV. Initiating activity of malonaldehyde as a carcinogen. , 1974, Journal of the National Cancer Institute.

[102]  A. Hewer,et al.  Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide , 1974, Nature.

[103]  G. Eisenbarth,et al.  Prostaglandin A1 inhibition of chondrosarcoma growth. , 1974, Biochemical and biophysical research communications.

[104]  J. Humes,et al.  Effects of indomethacin on Moloney sarcoma virus-induced tumors. , 1974, Prostaglandins.

[105]  B. Jaffe,et al.  The relationship between concentration of prostaglandin E and rates of cell replication. , 1974, Experimental cell research.

[106]  W. R. Bruce,et al.  IN VITRO PRODUCTION OF COLONY‐STIMULATING ACTIVITY. I. EXPOSURE OF MOUSE PERITONEAL CELLS TO ENDOTOXIN , 1974, Cell and tissue kinetics.

[107]  T. Powles,et al.  The Inhibition by Aspirin and Indomethacin of Osteolytic Tumour Deposits and Hypercalcaemia in Rats with Walker Tumour, and its Possible Application to Human Breast Cancer , 1973, British Journal of Cancer.

[108]  R. Boutwell,et al.  The early stimulation of phospholipid metabolism by 12-0-tetradecanoyl-phorbol-13-acetate and its specificity for tumor promotion. , 1973, Cancer research.

[109]  N. Galanti,et al.  Platelet—tumor‐cell interactions in mice. The role of platelets in the spread of malignant disease , 1973, International journal of cancer.

[110]  A. Tashjian,et al.  Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. , 1973, Prostaglandins.

[111]  A. Tashjian,et al.  EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2 , 1972, The Journal of experimental medicine.

[112]  R. Evans.  MACROPHAGES IN SYNGENEIC ANIMAL TUMOURS , 1972, Transplantation.

[113]  M. Moore,et al.  Physical separation of colony stimulating cells from in vitro colony forming cells in hemopoietic tissue , 1972, Journal of cellular physiology.

[114]  A. Tashjian,et al.  Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. , 1972, Biochemical and biophysical research communications.

[115]  K. Prasad.  Morphological differentiation induced by prostaglandin in mouse neuroblastoma cells in culture. , 1972, Nature: New biology.

[116]  J. Schooley,et al.  Stimulation of Erythropoiesis in Plethoric Mice by Prostaglandins and Its Inhibition by Antierythropoietin 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[117]  W. Baird,et al.  Tumor-promoting activity of phorbol and four diesters of phorbol in mouse skin. , 1971, Cancer research.

[118]  J. W. Smith,et al.  Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. , 1971, The Journal of clinical investigation.

[119]  J A Miller,et al.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.

[120]  Y. Ichikawa.  Differentiation of a cell line of myeloid leukemia , 1969, Journal of cellular physiology.

[121]  R. Foster,et al.  Behavior on Transfer of Serum Stimulated Bone Marrow Colonies.∗ , 1967 .

[122]  D. Metcalf,et al.  The growth of mouse bone marrow cells in vitro. , 1966, The Australian journal of experimental biology and medical science.

[123]  C. Heidelberger,et al.  The distribution of radioactivity in mice following administration of 3,4-benzpyrene-5-C14 and 1,2,5,6-dibenzanthracene-9,10-C14. , 1951, Cancer research.

[124]  E. Miller.  Studies on the formation of protein-bound derivatives of 3,4-benzpyrene in the epidermal fraction of mouse skin. , 1951, Cancer research.

[125]  P. Shubik,et al.  A New, Quantitative, Approach to the Study of the Stages of Chemical Carcinogenesis in the Mouse's Skin , 1947, British Journal of Cancer.

[126]  R. Bockman.  Prostaglandin production by human blood monocytes and mouse peritoneal macrophages: synthesis dependent on in vitro culture conditions. , 1981, Prostaglandins.

[127]  A. Miller,et al.  Arachidonic acid metabolism by rat chloroleukemia cells in culture. , 1981, Cancer research.

[128]  L. Marnett,et al.  Arachidonic acid-dependent metabolism of (+/-)-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to polyguanylic acid-binding derivatives. , 1981, Chemico-biological interactions.

[129]  K. Honn,et al.  Thromboxane synthetase inhibitors and prostacyclin can control tumor cell metastasis , 1980 .

[130]  J. Lindgren,et al.  Endogenous prostaglandin E2 production inhibits proliferation of polyoma virus-transformed 3T3 cells: correlation with cellular levels of cyclic AMP. , 1980, Advances in prostaglandin and thromboxane research.

[131]  R. Karmali,et al.  The relationship between concentrations of prostaglandin A1, E1, E2 and E2alpha and rates of cell proliferation. , 1979, Pharmacological research communications.

[132]  J. Salomon,et al.  Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. , 1979, Journal of the National Cancer Institute.

[133]  G. de Gaetano,et al.  Generation of Prostacyclin (PGI2) Activity by Lewis Lung Carcinoma (3LL) Cells , 1979, Thrombosis and Haemostasis.

[134]  E. Hecker,et al.  Inflammatory, tumor initiating and promoting activities of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro. , 1978, Cancer letters.

[135]  H. Bosmann,et al.  The inhibitory effect of heparin and warfarin treatments on the intravascular survival of B16 melanoma cells in syngeneic C57 mice. , 1978, Cell biology international reports.

[136]  H. Gastpar.  Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis. , 1977, Journal of medicine.

[137]  S. Sonis,et al.  Inhibition of lymphoma cell proliferation by supernatant from fibrosarcoma cultures: preliminary evidence that the inhibitory material is prostaglandin E. , 1977, Prostaglandins.

[138]  J. Levin,et al.  Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. , 1977, Medicine.

[139]  J. Dale,et al.  Effects of prostaglandins E1, E2, and F2alpha on the growth of leukaemia cells in culture. , 1976, Journal of cell science.

[140]  P. Alexander,et al.  The macrophage content of some human tumours. , 1975, Cancer letters.

[141]  E. Elias,et al.  Increasing the efficiency of cancer chemotherapy with heparin: “Clinical study” , 1973, Journal of surgical oncology.

[142]  B. L. Duuren.  Tumor-promoting agents in two-stage carcinogenesis. , 1969 .